Annis Gardner Whiting Capital Advisors, LLC Ionis Pharmaceuticals Inc Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $355 Billion
- Q3 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 9,936 shares of IONS stock, worth $324,211. This represents 0.11% of its overall portfolio holdings.
Number of Shares
9,936
Previous 9,396
5.75%
Holding current value
$324,211
Previous $448 Million
11.12%
% of portfolio
0.11%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
414Shares Held
136MCall Options Held
862KPut Options Held
617K-
Vanguard Group Inc Valley Forge, PA15.1MShares$491 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$462 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$337 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$285 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$257 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.63B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...